Planmed Oy, a Finland-based manufacturer of imaging solutions, announced this week that its Planmed Clarity 2D digital mammography system and Planmed Clarity 3D digital mammography tomosynthesis system have both received approval from Health Canada.

“This is a great next step for this unique product family,” Jan Moed, Planmed’s managing director, said in a prepared statement. “And we got the approval on the International Women’s Day, no less. I can’t think of a better way to celebrate Women’s Day.”

Moed also noted the importance of offering a 3D digital mammography solution.

“Planmed’s patented tomosynthesis method significantly improves image accuracy and allows even the smallest details to be captured with great precision,” she said. “The latest research indicates that tomosynthesis increases the cancer detection rate and reduces the recall rate.”